Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 185,056 | 140,193 | 90,066 | 112,170 | 75,323 |
| Depreciation Amortization | 9,936 | 6,347 | 2,959 | 11,005 | 8,100 |
| Income taxes - deferred | -25,992 | -45,676 | -44,463 | 42,624 | 34,740 |
| Accounts receivable | -19,268 | -5,131 | 1,930 | -15,289 | -10,342 |
| Accounts payable and accrued liabilities | 4,909 | 761 | 2,684 | 4,412 | 2,595 |
| Other Working Capital | -33,130 | -23,207 | -14,739 | -18,927 | -15,660 |
| Other Operating Activity | 60,295 | 33,904 | 8,194 | 56,551 | 41,391 |
| Operating Cash Flow | $181,806 | $107,191 | $46,631 | $192,546 | $136,147 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,796 | 23,888 | 51,080 | -118,499 | -61,739 |
| PPE Investments | -35,469 | -27,345 | -15,147 | -55,863 | -44,168 |
| Purchase Of Investment | -30,436 | -11,426 | -1,166 | -6,400 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -6,400 |
| Investing Cash Flow | $-80,701 | $-14,883 | $34,767 | $-180,762 | $-112,307 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -517 | -517 |
| Common Stock Issued | 12,419 | 11,988 | 5,798 | 11,697 | 8,689 |
| Other Financing Activity | -71,213 | -69,666 | -67,598 | -20,317 | -19,860 |
| Financing Cash Flow | $-58,794 | $-57,678 | $-61,800 | $-9,137 | $-11,688 |
| Exchange Rate Effect | -1,105 | -1,223 | -1,285 | 1,288 | -690 |
| Beginning Cash Position | 42,975 | 42,975 | 42,975 | 39,040 | 39,040 |
| End Cash Position | 84,181 | 76,382 | 61,288 | 42,975 | 50,502 |
| Net Cash Flow | $41,206 | $33,407 | $18,313 | $3,935 | $11,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | 181,806 | 107,191 | 46,631 | 192,546 | 136,147 |
| Capital Expenditure | -35,469 | -27,345 | -15,147 | -55,863 | -44,168 |
| Free Cash Flow | 146,337 | 79,846 | 31,484 | 136,683 | 91,979 |